Hap Trading, LLC Adaptimmune Therapeutics PLC Call Options Transaction History

Hap Trading, LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 12, 2022	SELL	$1.73 - $4.06 $26,123 - $61,305	-15,100 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$3.5 - $5.68 $10,500 - $17,040	3,000 Added 24.79%	15,100 $3,000
Q3 2021 Nov 10, 2021	SELL	$3.44 - $6.37 $7,568 - $14,014	-2,200 Reduced 15.38%	12,100 $5,000
Q2 2021 Aug 11, 2021	BUY	$3.86 - $5.78 $55,198 - $82,654	14,300 New	14,300 $5,000
Q1 2021 May 14, 2021	SELL	$4.9 - $6.83 $49,980 - $69,666	-10,200 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$4.0 - $9.2 $40,800 - $93,840	10,200 New	10,200 $20,000
Q3 2020 Nov 13, 2020	SELL	$7.66 - $10.78 $163,158 - $229,614	-21,300 Closed	0 $0
Q2 2020 Aug 10, 2020	BUY	$2.58 - $12.1 $54,954 - $257,730	21,300 New	21,300 $23,000

145M

60.8K

5.8K

Ticker ADAP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 163,370,000
Market Cap $96.4M
Description
Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.